Neurobiologist Wang Jing returns from US to lead institute at China's Shenzhen Bay Lab
Wang Jing resigned as chair and professor of the department of neurobiology at the University of California San Diego (UCSD) in January to assume the full-time position at the institute in southern China. The role marks a new direction in a career that has drawn on his experience in several disciplines, including engineering and biology.
Since starting at the laboratory, Wang said he had read every paper written by its young principal investigators, meticulously reviewing the researchers' work for months. He said the practice stemmed from a habit he developed at UCSD, which allows him to gain fresh perspectives from junior researchers quickly.
Wang has published more than 50 papers in prominent international journals, including Nature and Cell.
08:30
Why are more Chinese scientists leaving the US to return to China?
Why are more Chinese scientists leaving the US to return to China?
One paper that brought him significant global recognition, published in Nature in February 2022, used the fruit fly model to reveal the neuroscience underlying lust.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
an hour ago
- South China Morning Post
Did Zhuque-2E launch failure deal a blow to China's Guo Wang satellite project?
China's push to build broadband mega constellations could face further delays after one of the country's leading privately developed rockets failed after take-off last week from the Jiuquan Satellite Launch Centre in the Gobi Desert. The Zhuque-2E – an upgraded version of the LandSpace rocket that saw the company beat SpaceX in the race to send the world's first methane-fuelled projectile into orbit – experienced a flight anomaly after lift-off on Friday morning, the company said. LandSpace apologised to its unnamed clients and pledged to conduct a transparent investigation into the failure of the rocket, which successfully placed two satellites on its maiden flight in November. According to a Beijing-based space engineer who asked not to be named because of the issue's sensitivity, the lost payload is widely believed to consist of four experimental satellites for Guo Wang, China's state-backed network that aims to rival SpaceX's Starlink. The setback came a day after LandSpace – whose only active rocket is the Zhuque-2E – was named preferred bidder to launch orbiters for the Qianfan constellation, a Shanghai-backed initiative comparable in scale to Guo Wang's planned nearly 13,000 satellites. Both Guo Wang and Qianfan have stepped up launch efforts to meet their near-term deployment goals, but it is likely the Zhuque-2E failure may hit the Shanghai project harder, especially since it has not launched a single satellite since March. Guo Wang, which aims to have 400 satellites in orbit by 2027, has so far launched 72, while Qianfan's planned deployment of 648 by the end of this year remains stalled at 90.
South China Morning Post
2 hours ago
- South China Morning Post
Could Hong Kong scientists fight age-related muscle loss with help of HIV drug?
Hong Kong scientists have identified an HIV drug that could be used to treat a common condition behind age-related muscle loss, with researchers hoping to start clinical trials next year. Researchers from the Chinese University of Hong Kong (CUHK) said on Wednesday that they had tested the HIV drug, known as Maraviroc, on 18-month-old mice suffering from sarcopenia, a progressive age-related condition that causes loss of muscle mass and strength. The study found that mice saw significant improvements in their muscle mass, grip strength and running endurance after receiving high doses of the drug for three months. Dr Michael Ong Tim-yun, a clinical assistant professor at CUHK's orthopaedics and traumatology department, said one in seven people aged 65 and above in Hong Kong suffered from sarcopenia, with the amount rising to 50 per cent of residents over the age of 80. 'This figure might be an underestimation as many patients who actually have symptoms of sarcopenia are not aware of it,' Ong said. Ong, who is part of the research team, explained that sarcopenia could be diagnosed by measuring a person's muscle mass, handgrip strength and walking speed. The only treatments currently available are exercise and protein supplementation, with no drugs used to treat the condition at this point.
South China Morning Post
2 hours ago
- South China Morning Post
Chinese studio behind Black Myth: Wukong plans new game featuring Taoist ghost hunter
The Chinese video game studio behind the global hit Black Myth: Wukong, which played a role in shifting Beijing's attitude on the gaming industry, has begun developing a new title featuring a Taoist ghost hunter from Chinese folklore. Hangzhou-based Game Science, whose Wukong featured the Monkey King from the classic Chinese novel Journey to the West, said it had started developing a follow-up title called Black Myth: Zhong Kui. The announcement was made at Gamescom 2025 in Cologne, Germany. Feng Ji, the studio's founder, said the new title would feature 'a new hero, new gameplay, new visuals, new technology, and a new story', even though it would still be a single player console game. A short video demonstration of the game had received more than 9 million views on Chinese game fan platform Bilibili as of Wednesday afternoon. Black Myth: Zhong Kui was also one of the most searched terms on Chinese social media Weibo on Wednesday, with more than 300 million people discussing the topic. A promotional image from Black Myth: Zhong Kui. Photo: Handout Game Science did not provide a release schedule for the new game as it was still in the early stage of development.
